CREEK & RIVER (4763) Q2 2027 earnings summary

Executive summary

• H1 net sales reached ¥32,058M (+14.1%) and operating profit ¥2,760M (+32.7%), both record highs and above revised forecasts; ordinary profit was ¥2,760M (+34.4%).

• Parent-attributable profit declined 3.6% to ¥2,107.8M, reflecting lower acquisition-related gains than in the prior year; core growth, physician placement and improved investment-business profitability supported operating profit despite expansion costs.

Financial highlights

• Gross profit was ¥12,457.9M versus ¥10,487.6M; SG&A was ¥9,697.2M versus ¥8,407.1M. Gross margin improved 1.6 points to 38.9%, while the SG&A rate rose 0.3 points to 30.2%.

• Excluding Takahashi Shoten Group, H1 sales were ¥29,998M, operating profit ¥2,912M and interim net profit ¥1,845M; YoY comparisons were 108%, 134% and 111%, respectively.

• Comprehensive income was ¥2,169.8M versus ¥2,201.7M in the prior-year period.

Outlook and guidance

• FY27 forecasts: sales ¥66,500M (+8.3%), operating profit ¥5,650M (+14.4%) and ordinary profit ¥5,550M (+15.0%); forecasts were raised from July plans.

• Parent-attributable profit forecast is ¥3,550M (-13.5%), with basic EPS of ¥167.77; H1 interim profit forecast was raised to ¥2,107M.

• Takahashi Shoten Group expects H2 planner and calendar shipments to support FY27 sales of ¥7,800M and operating profit of ¥800M.